Greater than 95.0% as determined by SDS-PAGE
SNRPA Human Recombinant produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 34 kDa. SNRPA is expressed with a -6x His tag at N-terminus and purified by proprietary chromatographic techniques.
SNRPA binds to stem loop II of U1 small nuclear RNA (snRNA) and is essential for the recognition of the 5’ splice site of precursor mRNAs . This interaction is necessary for the subsequent binding of U2 snRNP and the U4/U6/U5 tri-snRNP, which together form the spliceosome . The spliceosome is responsible for removing introns from pre-mRNA and ligating exons to form mature mRNA .
In addition to its role in splicing, SNRPA has been implicated in the coupling of splicing and polyadenylation, a process that adds a poly(A) tail to the 3’ end of mRNA molecules . This polyadenylation is crucial for the stability, export, and translation of mRNA.
Recombinant SNRPA refers to the protein produced through recombinant DNA technology, where the SNRPA gene is cloned and expressed in a host organism, such as bacteria or yeast. This allows for the production of large quantities of the protein for research and therapeutic purposes. Recombinant SNRPA is used in various biochemical assays to study its function and interactions with other proteins and RNA molecules.
Research on SNRPA has provided significant insights into the mechanisms of RNA splicing and the regulation of gene expression. Studies have shown that SNRPA binds preferentially to the 5’-UGCAC-3’ motif on RNAs, which may be important for its function in splicing and polyadenylation . Additionally, recombinant SNRPA is used in structural studies to understand its interactions with other components of the spliceosome.